QSS
ALDR

Quantitative Systematic Strategies’s Alder Biopharmaceuticals ALDR Stock Holding History

Quantitative Systematic Strategies’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-14,194
Closed -$167K – 636
2019
Q2 		$167K Buy
+14,194
New +$172K 0.03% 423
2019
Q1 		– Sell
-27,527
Closed -$282K – 771
2018
Q4 		$282K Buy
27,527
+13,874
+102% +$178K 0.06% 433
2018
Q3 		$227K Buy
13,653
+538
+4% +$9.72K 0.04% 493
2018
Q2 		$207K Buy
13,115
+2,626
+25% +$39.9K 0.04% 552
2018
Q1 		$133K Sell
10,489
-3,539
-25% -$51.2K 0.03% 590
2017
Q4 		$161K Buy
14,028
+3,253
+30% +$36.3K 0.04% 509
2017
Q3 		$132K Buy
+10,775
New +$112K 0.04% 421
2016
Q1 		– Sell
-8,945
Closed -$303K – 907
2015
Q4 		$303K Buy
+8,945
New +$302K 0.08% 637

Other funds holding ALDR

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Quantitative Systematic Strategies's ALDR Position: Q3 2019 in Review

Quantitative Systematic Strategies sold out of Alder Biopharmaceuticals (ALDR) in Q3 2019, closing a stake of 14,194 shares — an estimated $167K sold.

Quantitative Systematic Strategies first reported a position in ALDR in Q4 2015 and held it in 8 quarters. The position peaked at $303K in Q4 2015. 143 funds tracked by Wall St. Rank hold ALDR as of Q3 2019.

  • Quantitative Systematic Strategies reported no remaining Alder Biopharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 14,194 Alder Biopharmaceuticals shares in Q3 2019, an estimated $167K.
  • Quantitative Systematic Strategies first reported a position in Alder Biopharmaceuticals in Q4 2015 and held it in 8 quarters.
  • Quantitative Systematic Strategies's Alder Biopharmaceuticals position peaked at $303K in Q4 2015.
  • 143 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q3 2019.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2019, filed 7 Nov 2019.